0
Respiratory Care |

Effectiveness of Early Noninvasive Ventilation Treatment for SevereRespiratory Failure Due to Community Acquired Pneumonia

Antonello Nicolini, MD
Author and Funding Information

Internal Medicine, Respiratory Diseases Unit, Sestri Levante, Italy


Chest. 2014;146(4_MeetingAbstracts):908A. doi:10.1378/chest.1961251
Text Size: A A A
Published online

Abstract

SESSION TITLE: Non-Ventilatory Respiratory Support

SESSION TYPE: Original Investigation Slide

PRESENTED ON: Monday, October 27, 2014 at 04:30 PM - 05:30 PM

PURPOSE: Severe community-acquired pneumonia ( CAP) have beendefined pneumonia requiring admission to the intensive care unit and use ofinvasive ventilation.The use of invasive ventilation can cause severalcomplications,as the admission to ICU.For this reason non-invasive ventilation(NIV) has been used to avoid andotracheal intubation.However,few studies havecurrently assessed definitively the usefulness of NIV in patients with CAP andsevere acute respiratory failure (ARF). An observational perspective study toassess the safety of NIV and predictors of NIV failure and hospital mortalitywas performed.

METHODS: We prospectively enrolled 65 patients with CAP and severeARF (paO2/FiO2<250);28 had "de novo" ARF and 37 previous cardiac andrespiratory disease.We defined successful NIV as avoidance of intubation and theachievement of PaO2/FiO2 >250 with spontaneous breathing.

RESULTS: NIV failed in 13 patients (20.0%) with a similar rate inpatients with "de novo" ARF and previous cardiac or respiratory disease(5/28)[17.8%] versus 8/37 [21.6%].Higher chest X-ray score at admission,higherheart rate after 1 h of NIV and a higher alveolar-arteriolar gradient ( A-aDO2)after 24 h of NIV independently predicted NIV failure.Higher chest X-rayscore,higher LDH at admission,higher heart rate and A-aDO2 after 24 h of NIVwere strictly related to hospital mortality

CONCLUSIONS: Successful treatment is strongly related to lessextension of the lung involvement and to a good initial and long-lastingresponse to the medical and NIV treatment

CLINICAL IMPLICATIONS: Our finding suggest that physician shouldconsider the use of NIV (when appropriate) for hospitalized patients with severepneumonia

DISCLOSURE: The following authors have nothing to disclose:Antonello Nicolini

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543